This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Uno, F. Articles by Ji, L. Search for Related Content PubMed PubMed Citation Articles by Uno, F. Articles by Ji, L.

Myristoylation of the Fus1 Protein Is Required for Tumor Suppression in Human Lung Cancer Cells

¹ Section of Thoracic Molecular Oncology, Department of Thoracic and Cardiovascular Surgery, and ² Department of Biomathematics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; ³ Department of Internal Medicine and Pharmacology, Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center, Dallas, Texas

FUS1 is a novel tumor suppressor gene identified in the human chromosome 3p21.3 region that is deleted in many cancers. Using surface-enhanced laser desorption/ionization mass spectrometric analysis on an anti-Fus1-antibody-capture ProteinChip array, we identified wild-type Fus1 as an N-myristoylated protein. N-myristoylation is a protein modification process in which a 14-carbon myristoyl group is cotranslationally and covalently added to the NH₂-terminal glycine residue of the nascent polypeptide. Loss of expression or a defect of myristoylation of the Fus1 protein was observed in human primary lung cancer and cancer cell lines. A myristoylation-deficient mutant of the Fus1 protein abrogated its ability to inhibit tumor cell-induced clonogenicity in vitro, to induce apoptosis in lung tumor cells, and to suppress the growth of tumor xenografts and lung metastases in vivo and rendered it susceptible to rapid proteasome-dependent degradation. Our results show that myristoylation is required for Fus1-mediated tumor-suppressing activity and suggest a novel mechanism for the inactivation of tumor suppressors in lung cancer and a role for deficient posttranslational modification in tumor suppressor-gene-mediated carcinogenesis.

This article has been cited by other articles:

				L. Du, J. J. Schageman, M. C. Subauste, B. Saber, S. M. Hammond, L. Prudkin, I. I. Wistuba, L. Ji, J. A. Roth, J. D. Minna, et al. miR-93, miR-98, and miR-197 Regulate Expression of Tumor Suppressor Gene FUS1 Mol. Cancer Res., August 1, 2009; 7(8): 1234 - 1243. [Abstract] [Full Text] [PDF]

				L. Prudkin, C. Behrens, D. D. Liu, X. Zhou, N. C. Ozburn, B. N. Bekele, J. D. Minna, C. Moran, J. A. Roth, L. Ji, et al. Loss and Reduction of Fus1 Protein Expression is a Frequent Phenomenon in the Pathogenesis of Lung Cancer Clin. Cancer Res., January 1, 2008; 14(1): 41 - 47. [Abstract] [Full Text] [PDF]

				D. Y. Lee, Z. Deng, C.-H. Wang, and B. B. Yang MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression PNAS, December 18, 2007; 104(51): 20350 - 20355. [Abstract] [Full Text] [PDF]

				G. Jayachandran, J.-i. Sazaki, M. Nishizaki, K. Xu, L. Girard, J. D. Minna, J. A. Roth, and L. Ji Fragile Histidine Triad Mediated Tumor Suppression of Lung Cancer by Targeting Multiple Components of the Ras/Rho GTPase Molecular Switch Cancer Res., November 1, 2007; 67(21): 10379 - 10388. [Abstract] [Full Text] [PDF]

				S. Ohtani, A. Iwamaru, W. Deng, K. Ueda, G. Wu, G. Jayachandran, S. Kondo, E. N. Atkinson, J. D. Minna, J. A. Roth, et al. Tumor Suppressor 101F6 and Ascorbate Synergistically and Selectively Inhibit Non-Small Cell Lung Cancer Growth by Caspase-Independent Apoptosis and Autophagy Cancer Res., July 1, 2007; 67(13): 6293 - 6303. [Abstract] [Full Text] [PDF]

				D. Angeloni Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease Brief Funct Genomic Proteomic, May 24, 2007; (2007) elm007v1. [Abstract] [Full Text] [PDF]

				W.-G. Deng, H. Kawashima, G. Wu, G. Jayachandran, K. Xu, J. D. Minna, J. A. Roth, and L. Ji Synergistic Tumor Suppression by Coexpression of FUS1 and p53 Is Associated with Down-regulation of Murine Double Minute-2 and Activation of the Apoptotic Protease-Activating Factor 1-Dependent Apoptotic Pathway in Human Non-Small Cell Lung Cancer Cells Cancer Res., January 15, 2007; 67(2): 709 - 717. [Abstract] [Full Text] [PDF]

				K. Ueda, H. Kawashima, S. Ohtani, W.-G. Deng, M. Ravoori, J. Bankson, B. Gao, L. Girard, J. D. Minna, J. A. Roth, et al. The 3p21.3 Tumor Suppressor NPRL2 Plays an Important Role in Cisplatin-Induced Resistance in Human Non-Small-Cell Lung Cancer Cells Cancer Res., October 1, 2006; 66(19): 9682 - 9690. [Abstract] [Full Text] [PDF]

				J. J. Oh, A. Razfar, I. Delgado, R. A. Reed, A. Malkina, B. Boctor, and D. J. Slamon 3p21.3 Tumor Suppressor Gene H37/Luca15/RBM5 Inhibits Growth of Human Lung Cancer Cells through Cell Cycle Arrest and Apoptosis. Cancer Res., April 1, 2006; 66(7): 3419 - 3427. [Abstract] [Full Text] [PDF]